^
Association details:
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Title:

Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma

Excerpt:
Notably, up‐regulation of Oct4 and Nanog expression was significantly observed in cisplatin‐resistant patients with OSCC (**P<0.01).
DOI:
10.1111/j.1600-0714.2011.01015.x